首页> 外文期刊>Surgery >Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis.
【24h】

Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis.

机译:预防外科手术患者中的金黄色葡萄球菌感染:超越传统的围手术期预防措施。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Health care-related infections cause significant patient morbidity and mortality rates and add excess costs that frequently are not reimbursed. Staphylococcus aureus has long been recognized as an important pathogen in human disease and is the most common cause of nosocomial infections. METHOD: The objective of this review of the English language literature and a MEDLINE search was to describe recent advances in the prevention of S aureus health care-related infections that are attributable to patients' endogenous colonization. The ecologic niche of S aureus is the anterior nares and nasal carriage increases the risk of the development of a surgical-site, lower respiratory tract, or bloodstream infection. S aureus carriers have a 2- to 9-fold increased risk of the development of a surgical-site or intravenous catheter infection. RESULTS: Three treatment strategies may eliminate nasal carriage: locally applied antibiotics or disinfectants, systemic antibiotics, and bacterial interference. Among these strategies, locally applied or systemic antibiotics are used most commonly. Nasal ointments or sprays and oral antibiotics have variable efficacy, and their use frequently results in antimicrobial resistance among S aureus strains. Of the commonly used agents, mupirocin (pseudomonic acid) ointment has been shown to be 97% effective in reducing S aureus nasal carriage. In a recently published randomized, double-blind, placebo-controlled trial to determine whether intranasal mupirocin reduced the rate of S aureus-infected surgical-site and other S aureus health care-related infections; 4% of S aureus nasal carriers who received mupirocin acquired S aureus health care-related infections compared with 7.7% of S aureus nasal carriers who received placebo (P=.02). The S aureus surgical-site infection rate was not reduced significantly, but carriers who received mupirocin before cardiothoracic or general surgery operations had almost 50% fewer S aureus surgical-site infections than carriers who received placebo. In this setting resistance rarely has been reported. CONCLUSIONS: Given the importance of S aureus nosocomial infections and the increased risk of S aureus nasal carriage in patients with health care-related infections, investigators must study cost-effective strategies to further prevent certain types of health care-related infections or nosocomial infections that occur in specific settings. One potential strategy is to decrease or eliminate S aureus nasal carriage among certain patient populations or in certain healthcare settings.
机译:背景:与卫生保健有关的感染会导致大量的患者发病率和死亡率,并增加经常无法报销的额外费用。长期以来,金黄色葡萄球菌一直被认为是人类疾病中的重要病原体,并且是医院感染的最常见原因。方法:这篇英语文献综述和MEDLINE搜索的目的是描述预防由于患者内源性定植而引起的金黄色葡萄球菌相关的感染的最新进展。金黄色葡萄球菌的生态位是前鼻孔和鼻腔运输增加了发生手术部位,下呼吸道或血液感染的风险。金黄色葡萄球菌携带者发生手术部位或静脉内导管感染的风险增加2到9倍。结果:三种治疗策略可以消除鼻腔运输:局部应用抗生素或消毒剂,全身性抗生素和细菌干扰。在这些策略中,最常用的是局部应用或全身性抗生素。鼻药膏或喷雾剂以及口服抗生素的疗效不尽相同,经常使用它们会导致金黄色葡萄球菌菌株产生抗药性。在常用药物中,莫匹罗星(psdomomonic acid)软膏已被证明在减少金黄色葡萄球菌鼻腔运输方面有效率为97%。在最近发表的一项随机,双盲,安慰剂对照试验中,确定鼻内莫匹罗星是否能降低金黄色葡萄球菌感染的手术部位和其他金黄色葡萄球菌保健相关感染的发生率;接受莫匹罗星的金黄色葡萄球菌鼻携带者中有4%感染了与金黄色葡萄球菌有关的感染,而接受安慰剂的金黄色葡萄球菌鼻携带者中有7.7%的人感染了Pup(0.02)。金黄色葡萄球菌的外科手术部位感染率没有显着降低,但是在心胸或普外科手术之前接受莫匹罗星的携带者比接受安慰剂的携带者的金黄色葡萄球菌手术部位感染少了近50%。在这种情况下,很少有关于电阻的报道。结论:鉴于金黄色葡萄球菌医院感染的重要性以及与医疗保健有关的感染患者中金黄色葡萄球菌经鼻运输的风险增加,研究人员必须研究具有成本效益的策略,以进一步预防某些类型的与医疗保健有关的感染或医院感染发生在特定的设置中。一种潜在的策略是减少或消除某些患者人群中或某些医疗机构中的金黄色葡萄球菌鼻腔运输。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号